(-)-epigallocatechin 3-gallate multiple interactions ISO LATS2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LATS2 mRNA CTD PMID:22079256 (20S)-ginsenoside Rg3 increases expression ISO LATS2 (Homo sapiens) 6480464 ginsenoside Rg3 results in increased expression of LATS2 mRNA CTD PMID:31916386 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of LATS2 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO LATS2 (Homo sapiens) 6480464 Estradiol results in decreased expression of LATS2 mRNA CTD PMID:24758408 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO LATS2 (Homo sapiens) 6480464 2 more ... CTD PMID:19095052 2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LATS2 mRNA CTD PMID:21570461 2-methoxyethanol increases expression ISO Lats2 (Rattus norvegicus) 6480464 methyl cellosolve results in increased expression of LATS2 mRNA CTD PMID:21061450 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bisphenol S affects the methylation of LATS2 gene CTD PMID:31683443 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of LATS2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects methylation ISO LATS2 (Homo sapiens) 6480464 Decitabine affects the methylation of LATS2 promoter CTD PMID:17049657 5-aza-2'-deoxycytidine multiple interactions ISO LATS2 (Homo sapiens) 6480464 [Decitabine affects the methylation of LATS2 promoter] which affects the expression of LATS2 mRNA CTD PMID:17049657 6-propyl-2-thiouracil increases expression ISO Lats2 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of LATS2 mRNA CTD PMID:24780913 acrylamide increases expression ISO LATS2 (Homo sapiens) 6480464 Acrylamide results in increased expression of LATS2 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LATS2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO LATS2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of LATS2 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO LATS2 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of LATS2 intron CTD PMID:30157460 antirheumatic drug increases expression ISO LATS2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of LATS2 mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO LATS2 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to LATS2 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO LATS2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LATS2 mRNA CTD PMID:20458559 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of LATS2 mRNA CTD PMID:33463082 benzo[a]pyrene multiple interactions EXP 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to LATS2 promoter] CTD PMID:19654925 benzo[a]pyrene affects methylation ISO LATS2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of LATS2 intron CTD PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO LATS2 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 bisphenol A affects expression ISO LATS2 (Homo sapiens) 6480464 bisphenol A affects the expression of LATS2 mRNA CTD PMID:20170705 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LATS2 mRNA CTD PMID:32156529 bisphenol A decreases expression ISO Lats2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of LATS2 mRNA CTD PMID:30816183 more ... bisphenol A increases methylation ISO Lats2 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of LATS2 gene CTD PMID:28505145 bisphenol A affects expression ISO Lats2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of LATS2 mRNA CTD PMID:25181051 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of LATS2 mRNA CTD PMID:30951980 C60 fullerene decreases expression ISO Lats2 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of LATS2 mRNA CTD PMID:19167457 caffeine decreases phosphorylation ISO LATS2 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of LATS2 protein CTD PMID:35688186 carbamazepine affects expression ISO LATS2 (Homo sapiens) 6480464 Carbamazepine affects the expression of LATS2 mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon analog results in decreased expression of LATS2 mRNA CTD PMID:25554681 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LATS2 gene CTD PMID:20938992 cisplatin multiple interactions ISO LATS2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of LATS2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO LATS2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of LATS2 mRNA CTD PMID:27392435 copper atom multiple interactions ISO LATS2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of LATS2 mRNA CTD PMID:20971185 copper atom affects binding ISO LATS2 (Homo sapiens) 6480464 Copper binds to LATS2 protein CTD PMID:35027733 copper atom decreases expression ISO LATS2 (Homo sapiens) 6480464 Copper results in decreased expression of LATS2 protein CTD PMID:16246896 copper(0) multiple interactions ISO LATS2 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of LATS2 mRNA CTD PMID:20971185 copper(0) affects binding ISO LATS2 (Homo sapiens) 6480464 Copper binds to LATS2 protein CTD PMID:35027733 copper(0) decreases expression ISO LATS2 (Homo sapiens) 6480464 Copper results in decreased expression of LATS2 protein CTD PMID:16246896 copper(II) sulfate increases expression ISO LATS2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of LATS2 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO LATS2 (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of LATS2 protein CTD PMID:35688186 crocidolite asbestos increases expression ISO LATS2 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of LATS2 mRNA CTD PMID:18687144 crocidolite asbestos decreases expression EXP 6480464 Asbestos and Crocidolite results in decreased expression of LATS2 mRNA CTD PMID:29279043 CU-O LINKAGE increases expression ISO LATS2 (Homo sapiens) 6480464 cupric oxide results in increased expression of LATS2 mRNA CTD PMID:22077320 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of LATS2 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO LATS2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of LATS2 mRNA CTD PMID:25562108 diarsenic trioxide increases expression ISO LATS2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of LATS2 mRNA CTD PMID:20458559 diazinon affects expression ISO Lats2 (Rattus norvegicus) 6480464 Diazinon affects the expression of LATS2 mRNA CTD PMID:22546817 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of LATS2 mRNA CTD PMID:17361019 and PMID:21266533 diuron decreases expression ISO Lats2 (Rattus norvegicus) 6480464 Diuron results in decreased expression of LATS2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO LATS2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LATS2 mRNA CTD PMID:27188386 doxorubicin increases expression ISO LATS2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of LATS2 mRNA CTD PMID:29803840 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of LATS2 mRNA CTD PMID:35436446 ethyl methanesulfonate increases expression ISO LATS2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of LATS2 mRNA CTD PMID:23649840 fenamidone increases expression EXP 6480464 fenamidone results in increased expression of LATS2 mRNA CTD PMID:27029645 fisetin increases phosphorylation ISO LATS2 (Homo sapiens) 6480464 fisetin results in increased phosphorylation of LATS2 protein CTD PMID:31044527 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LATS2 gene CTD PMID:20938992 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of LATS2 mRNA CTD PMID:25629700 formaldehyde increases expression ISO LATS2 (Homo sapiens) 6480464 Formaldehyde results in increased expression of LATS2 mRNA CTD PMID:23649840 hydrogen cyanide decreases expression EXP 6480464 Hydrogen Cyanide results in decreased expression of LATS2 mRNA CTD PMID:33914522 hydrogen peroxide affects expression ISO LATS2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of LATS2 mRNA CTD PMID:20044591 iron dichloride increases expression ISO LATS2 (Homo sapiens) 6480464 ferrous chloride results in increased expression of LATS2 mRNA CTD PMID:35984750 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LATS2 gene CTD PMID:20938992 menadione affects expression ISO LATS2 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of LATS2 mRNA CTD PMID:20044591 methoxychlor affects methylation ISO Lats2 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of LATS2 gene CTD PMID:35440735 methyl methanesulfonate increases expression ISO LATS2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of LATS2 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO LATS2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of LATS2 mRNA CTD PMID:28001369 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO LATS2 (Homo sapiens) 6480464 N more ... CTD PMID:18778698 and PMID:35027733 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO LATS2 (Homo sapiens) 6480464 N more ... CTD PMID:18778698 oxaliplatin multiple interactions ISO Lats2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LATS2 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO Lats2 (Rattus norvegicus) 6480464 oxaliplatin results in increased expression of LATS2 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LATS2 mRNA CTD PMID:34911549 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of LATS2 mRNA CTD PMID:17562736 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of LATS2 mRNA CTD PMID:23091169 potassium chloride multiple interactions ISO LATS2 (Homo sapiens) 6480464 [Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of LATS2 mRNA CTD PMID:29691375 potassium chromate multiple interactions ISO LATS2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LATS2 mRNA CTD PMID:22079256 potassium chromate increases expression ISO LATS2 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of LATS2 mRNA CTD PMID:22079256 potassium cyanide decreases expression EXP 6480464 Potassium Cyanide results in decreased expression of LATS2 mRNA CTD PMID:33914522 SB 431542 multiple interactions ISO LATS2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LATS2 mRNA CTD PMID:27188386 silver atom increases expression ISO LATS2 (Homo sapiens) 6480464 Silver results in increased expression of LATS2 mRNA CTD PMID:26014281 silver(0) increases expression ISO LATS2 (Homo sapiens) 6480464 Silver results in increased expression of LATS2 mRNA CTD PMID:26014281 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of LATS2 mRNA CTD PMID:17484886 thalidomide increases expression ISO LATS2 (Homo sapiens) 6480464 Thalidomide analog results in increased expression of LATS2 mRNA CTD PMID:20525221 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of LATS2 mRNA CTD PMID:23557971 topotecan multiple interactions ISO Lats2 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of LATS2 mRNA CTD PMID:25729387 topotecan increases expression ISO Lats2 (Rattus norvegicus) 6480464 Topotecan results in increased expression of LATS2 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO LATS2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of LATS2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO LATS2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LATS2 mRNA CTD PMID:27188386 triptonide affects expression EXP 6480464 triptonide affects the expression of LATS2 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of LATS2 mRNA CTD PMID:28973697 tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of LATS2 mRNA CTD PMID:30912803 urethane increases expression ISO LATS2 (Homo sapiens) 6480464 Urethane results in increased expression of LATS2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO LATS2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of LATS2 mRNA CTD PMID:23179753 valproic acid affects expression ISO LATS2 (Homo sapiens) 6480464 Valproic Acid affects the expression of LATS2 mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of LATS2 mRNA CTD PMID:34182078 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of LATS2 mRNA CTD PMID:36642194 zinc atom multiple interactions ISO LATS2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of LATS2 mRNA more ... CTD PMID:18593933 and PMID:35027733 zinc atom affects binding ISO LATS2 (Homo sapiens) 6480464 Zinc binds to LATS2 protein CTD PMID:35027733 zinc(0) multiple interactions ISO LATS2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of LATS2 mRNA more ... CTD PMID:18593933 and PMID:35027733 zinc(0) affects binding ISO LATS2 (Homo sapiens) 6480464 Zinc binds to LATS2 protein CTD PMID:35027733
